Development of novel thymus-directed strategy for central immune tolerance induction in hemophilia A
Project/Area Number |
24591430
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Jichi Medical University |
Principal Investigator |
MADOIWA Seiji 自治医科大学, 医学部, 講師 (70296119)
|
Co-Investigator(Kenkyū-buntansha) |
KOBAYASHI Eiji 自治医科大学, 医学部, 客員教授 (00245044)
OHMORI Tsukasa 自治医科大学, 医学部, 講師 (70382843)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 血友病 / インヒビター / 免疫寛容 / 人工多能性幹細胞 / 遺伝子治療 / 細胞移植療法 / 胸腺上皮細胞 / 細胞療法 |
Outline of Final Research Achievements |
Hemophilia A is an X-linked, recessive hereditary bleeding disorder due to deficient coagulation factor VIII (FVIII). However, about 30% of patients with severe deficiency develop inhibitors or circulating alloantibodies against infused factor VIII. Once an inhibitor develops, treatment of bleeding episodes is quite difficult due to partial or complete lack of efficacy of replacement therapy. Immune tolerance induction (ITI) by prolonged administration of FVIII concentrates is currently the only therapy proven to eliminate persistent inhibitors in severe hemophilia A. In this project, we investigated central ITI by thymic implantation of epithelial progenitor cells derived from induced pluripotent stem (iPS) cells, which will be isolated from fibroblasts of congenic hemophilia A mice and transduced with the SIV encoding FVIII.
|
Report
(4 results)
Research Products
(28 results)
-
-
-
[Journal Article] Addition of recommendations for the use of recombinant human thrombomodulin to the "Expert consensus for the treatment of disseminated intravascular coagulation in Japan"2014
Author(s)
Wada, H., D. I. C. s. Japanese Society of Thrombosis Hemostasis, K. Okamoto, T. Iba, S. Kushimoto, K. Kawasugi, S. Gando, S. Madoiwa, T. Uchiyama, T. Mayumi, and Y. Seki.
-
Journal Title
Thromb Res
Volume: 2014
Issue: 4
Pages: 924-925
DOI
Related Report
Peer Reviewed
-
[Journal Article] Living donor liver transplantation from an asymptomatic donor with mild coagulation factor IX deficiency: report of a case.2014
Author(s)
Sanada, Y., H. Sasanuma, Y. Sakuma, K. Morishima, N. Kasahara, Y. Kaneda, A. Miki, T. Fujiwara, A. Shimizu, M. Hyodo, Y. Hirata, N. Yamada, N. Okada, Y. Ihara, T. Urahashi, S. Madoiwa, J. Mimuro, K. Mizuta, and Y. Yasuda.
-
Journal Title
Pediatr Transplant
Volume: 18
Issue: 8
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals.2014
Author(s)
Mimuro J, Mizukami H, Shima M, Matsushita T, Taki M, Muto S, Higasa S, Sakai M, Ohmori T, Madoiwa S, Ozawa K, and Sakata Y.
-
Journal Title
J. Med. Virol.
Volume: 86
Issue: 11
Pages: 1990-1997
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.2014
Author(s)
Koyama, K., S. Madoiwa, S. Nunomiya, T. Koinuma, M. Wada, A. Sakata, T. Ohmori, J. Mimuro, and Y. Sakata.
-
Journal Title
Crit Care
Volume: 18
Issue: 1
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Acquired factor v inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.2013
Author(s)
Ashizawa M, Kimura S, Wada H, Sakamoto K, Sato M, Terasako K, Kikuchi M, Nakasone H, Okuda S, Kako S, Yamazaki R, Oshima K, Matsuura K, Ohmori T, Madoiwa S, Nishida J, Mimuro J, Tabei K, Sakata Y, Kanda Y.
-
Journal Title
Hematology
Volume: 18
Issue: 5
Pages: 300-304
DOI
Related Report
Peer Reviewed
-
[Journal Article] 分娩後後天性血友病の2例.2013
Author(s)
野城聡志, 翁家国, 岡塚貴世志, 藤原慎一郎, 大嶺謙, 鈴木隆浩, 森政樹, 永井正, 室井一男, 小澤敬也, 窓岩清治.
-
Journal Title
臨床血液
Volume: 54
Pages: 2100-2100
Related Report
Peer Reviewed
-
[Journal Article] 血友病aクローンブタ2013
Author(s)
柏倉裕志, 三室淳, 大西彰, 岩元正樹, 窓岩清治, 淵本大一郎, 鈴木俊一, 鈴木美佐枝, 千本昭一郎, 石渡彰, 安本篤史, 坂田飛鳥, 大森司, 橋本径子, 矢崎智子, 坂田洋一
-
Journal Title
日本血栓止血学会誌
Volume: 24
Pages: 224-224
Related Report
-
[Journal Article] インヒビター保有先天性血友病患者に対する止血治療ガイドライン 2013年改訂版2013
Author(s)
酒井 道生(産業医科大学 小児科), 瀧 正志, 家子 正裕, 井田 孔明, 大平 勝美, 勝沼 俊雄, 高橋 芳右, 野上 恵嗣, 日笠 聡, 福武 勝幸, 松下 功, 松本 雅則, 窓岩 清治, 天野 景裕, 岡 敏明, 荻原 建一, 澤田 暁宏, 嶋 緑倫, 白幡 聡, 鈴木 隆史, 竹谷 英之, 花房 秀次, 堀越 泰雄, 松下 正, 松本 剛史, 三室 淳, 吉岡 章
-
Journal Title
日本血栓止血学会誌
Volume: 24
Pages: 640-658
Related Report
-
[Journal Article] Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis2013
Author(s)
Koyama, K., Madoiwa, S., Tanaka, S., Koinuma, T., Wada, M., Sakata, A., Ohmori, T., Mimuro, J., Nunomiya, S. and Sakata, Y.
-
Journal Title
J Crit Care
Volume: in press
Issue: 5
Pages: 556-563
DOI
Related Report
Peer Reviewed
-
[Journal Article] Minimizing the inhibitory effect of neutralizing antibody for efficient gene expression in the liver with adeno-associated virus 8 vectors.2013
Author(s)
Mimuro J, Mizukami H, Hishikawa S, Ikemoto T, Ishiwata A, Sakata A, Ohmori T, Madoiwa S, Ono F, Ozawa K, and Sakata Y
-
Journal Title
Mol Ther
Volume: 21
Issue: 2
Pages: 318-323
DOI
Related Report
Peer Reviewed
-
[Journal Article] Tissue plasminogen activator (tPA) deficiency promotes early phase regeneration in the olfactory epithelium after bulbectomy2013
Author(s)
Makino N, Madoiwa S, Ohmori T, Katoh K, Ookawara S, Kanazawa T, Matsuo O, Ichikawa M, Mimuro J, Ichimura K, Sakata Y
-
Journal Title
International Forum of Allergy & Rhinology
Volume: 3
Issue: 6
Pages: 458-467
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Il2rg gene-targeted severe combined immunodeficiency pigs2012
Author(s)
Suzuki S, Iwamoto M, Saito Y, Fuchimoto D, Sembon S, Suzuki M, Mikawa S, Hashimoto M, Aoki Y, Najima Y, Takagi S, Suzuki N, Suzuki E, Kubo M, Mimuro J, Kashiwakura Y, Madoiwa S, et al.
-
Journal Title
Cell Stem Cell
Volume: 10
Issue: 6
Pages: 753-758
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] Regulation of plasminogen activator inhibitor -1 promotes immune tolerance to factor VIII in murine hemophilia A.2013
Author(s)
Seiji Madoiwa, Tsukasa Ohmori, Toshio Miyata, Takashi Dan, Yuji Kashiwakura, Asuka Sakata, Jun Mimuro, Kiyotaka Okada, Shigeru Ueshima, Hitoshi Endo, Makoto Inoue, Mamoru Hasegawa, Osamu Matsuo, Keiya Ozawa, Yoichi Sakata
Organizer
2013 Congress of Internationl Society on Thrombosis and Haemostasis
Place of Presentation
Amsterdam, Netherland
Related Report
-
[Presentation] REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR-1 REDUCES IMMUNE RESPONSE TO FACTOR VIII IN MURINE HEMOPHILIA A.2013
Author(s)
Seiji Madoiwa, Tsukasa Ohmori, Toshio Miyata, Takashi Dan, Yuji Kashiwakura, Asuka Sakata, Jun Mimuro, Kiyotaka Okada, Shigeru Ueshima, Hitoshi Endo, Makoto Inoue, Mamoru Hasegawa, Osamu Matsuo, Keiya Ozawa, Yoichi Sakata
Organizer
2013 East Asia Hemophilia Forum
Place of Presentation
Seoul, South Korea
Related Report
Invited
-